Form 4: DocuSign Director Sells Shares Under 10b5-1 Plan

A DocuSign director, Teresa Briggs, sold 534 shares of common stock at $94.60 per share on December 16, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Teresa Briggs, a director at DocuSign, sold 534 shares of the company's common stock on December 16, 2024.
• The sale was executed at a price of $94.60 per share.
• This transaction was conducted under a pre-established Rule 10b5-1 trading plan.
• Following the transaction, Ms. Briggs directly owns 7,736 shares of DocuSign stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an insider stock sale under a pre-arranged plan, which is neither positive nor negative.

Industry Context

This is a routine disclosure of an insider transaction. It is common for executives and directors to use 10b5-1 plans to manage their stock sales and avoid accusations of insider trading.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US.
• The use of 10b5-1 plans is a common method for corporate insiders to sell shares without raising concerns about insider trading.
• The transaction is relatively small in the context of the overall market capitalization of DocuSign.

Stakeholder Impact

• The sale is unlikely to have a significant impact on stakeholders given the relatively small number of shares sold and the pre-planned nature of the transaction.

Key Dates

Keywords

DocuSign, insider trading, Form 4, Teresa Briggs, stock sale, Rule 10b5-1, director